Yahoo
OTC Markets OTCPK - Delayed Quote USD

Fifty 1 Labs, Inc. (FITY)

0.0001 -0.0001 (-50.00%)
As of October 30 at 5:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for FITY
  • Previous Close 0.0002
  • Open 0.0001
  • Bid 0.0001 x --
  • Ask 0.0002 x 8476640400
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0021
  • Volume 27,237,150
  • Avg. Volume 19,114,455
  • Market Cap (intraday) 118,531
  • Beta (5Y Monthly) 3.92
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Fifty 1 Labs, Inc., a biotechnology and life sciences company, which focuses on peptide products, peptide discovery, AI-enabled research, and clinical development in the United States. The company provides sports supplements; peptides; telepath products, as well as health and wellness solutions. It offers supplements such as, pre-workout formulas, BCAAS, ION+ electrolyte formula, turmeric gummies, and ashwagandha gummies. The company was formerly known as Consumer Automotive Finance, Inc. and changed its name to Fifty 1 Labs, Inc. in March 2025. Fifty 1 Labs, Inc. was incorporated in 1998 and is based in Vancouver, Canada.

fifty1labs.com

2

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

FITY
80.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

FITY
94.44%
S&P 500 (^GSPC)
11.11%

3-Year Return

FITY
99.00%
S&P 500 (^GSPC)
81.91%

5-Year Return

FITY
99.82%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    47

  • Net Income Avi to Common (ttm)

    -656.25k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    140

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: